神经科指南

订阅

MedSci主页 / 所有栏目 / 神经科指南

2016 中国偏头痛防治指南

2016-10-15 中国疼痛医学杂志.2016,22(10):721-727.

偏头痛

根据我国偏头痛诊疗现状的研究，我国目前对偏头痛患者的治疗仍然存在很大不足，主要体现在预防性治疗不充分，患者就诊率不高，以及镇痛药物过度使用等，为进一步指导和规范我国广大医师对偏头痛的治疗，中华医学会疼痛学分会头面痛学组、中国医师协会神经内科医师分会疼痛和感觉障碍专委会制订了本指南，适用于神经科、全科、普通内科及疼痛科医师。

中文标题：

2016 中国偏头痛防治指南

发布机构：

发布日期：

2016-10-15

简要介绍：

根据我国偏头痛诊疗现状的研究，我国目前对偏头痛患者的治疗仍然存在很大不足，主要体现在预防性治疗不充分，患者就诊率不高，以及镇痛药物过度使用等，为进一步指导和规范我国广大医师对偏头痛的治疗，中华医学会疼痛学分会头面痛学组、中国医师协会神经内科医师分会疼痛和感觉障碍专委会制订了本指南，适用于神经科、全科、普通内科及疼痛科医师。

制定者：
中华医学会疼痛学分会头面痛学组 
中国医师协会神经内科医师分会 
疼痛和感觉障碍专委会 

相关资料下载：
[AttachmentFileName(sort=100, fileName=2016 中国偏头痛防治指南)] GetToolGuiderByIdResponse(projectId=1, id=445a11c00131e73d, title=2016 中国偏头痛防治指南, enTitle=, guiderFrom=中国疼痛医学杂志.2016,22(10):721-727., authorId=null, author=, summary=根据我国偏头痛诊疗现状的研究，我国目前对偏头痛患者的治疗仍然存在很大不足，主要体现在预防性治疗不充分，患者就诊率不高，以及镇痛药物过度使用等，为进一步指导和规范我国广大医师对偏头痛的治疗，中华医学会疼痛学分会头面痛学组、中国医师协会神经内科医师分会疼痛和感觉障碍专委会制订了本指南，适用于神经科、全科、普通内科及疼痛科医师。, cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Sat Oct 15 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=<div>根据我国偏头痛诊疗现状的研究，我国目前对偏头痛患者的治疗仍然存在很大不足，主要体现在预防性治疗不充分，患者就诊率不高，以及镇痛药物过度使用等，为进一步指导和规范我国广大医师对偏头痛的治疗，中华医学会疼痛学分会头面痛学组、中国医师协会神经内科医师分会疼痛和感觉障碍专委会制订了本指南，适用于神经科、全科、普通内科及疼痛科医师。<br> </div> <span style="font-weight: bold;"> <div><span style="font-weight: bold;"><br> </span></div> 制定者： </span><br> 中华医学会疼痛学分会头面痛学组  <div>中国医师协会神经内科医师分会 </div> <div>疼痛和感觉障碍专委会 </div> <div><br> 拓展指南：<strong>与<font color=red>偏头痛</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=2ad671c001103aa4" title="2014 EHF共识声明：难治性慢性偏头痛的临床定义" target=_blank>2014 EHF共识声明：难治性慢性偏头痛的临床定义</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=d169a1c00090aea9" title="2012AAN NSAID和其他补充剂防治成人发作性偏头痛循证指南" target=_blank>2012AAN NSAID和其他补充剂防治成人发作性偏头痛循证指南</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=246a51c00090a664" title="2012 AAN 成人阵发性偏头痛预防药物治疗循证指南" target=_blank>2012 AAN 成人阵发性偏头痛预防药物治疗循证指南</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=daec61c000881546" title="偏头痛药物对照试验指南：第3版" target=_blank>偏头痛药物对照试验指南：第3版</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=f05721c00081e0ca" title="2011 中国偏头痛诊断治疗指南" target=_blank>2011 中国偏头痛诊断治疗指南</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E5%81%8F%E5%A4%B4%E7%97%9B" target=_blank>有关偏头痛更多指南</a></ul></div>, tagList=[TagDto(tagId=1305, tagName=偏头痛)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=21049, categoryName=偏头痛网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9805, appHits=1322, showAppHits=0, pcHits=6513, showPcHits=3300, likes=201, shares=100, comments=15, approvalStatus=1, publishedTime=Fri Oct 28 15:19:46 CST 2016, publishedTimeString=2016-10-15, pcVisible=1, appVisible=1, editorId=5295957, editor=lili, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=lili, createdTime=Fri Oct 28 15:19:46 CST 2016, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 14:50:50 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016 中国偏头痛防治指南)])
2016 中国偏头痛防治指南
下载请点击：
评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1210257, encodeId=e2b5121025e87, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecd78109752, createdName=ms7000001622695942, createdTime=Mon Apr 11 11:14:01 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073423, encodeId=379910e3423f3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d14a5680833, createdName=ms7000001489181623, createdTime=Wed Nov 24 09:02:40 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894672, encodeId=96b28946e258, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28d31772992, createdName=ms2071255438096128, createdTime=Mon Oct 26 23:51:31 CST 2020, time=2020-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893903, encodeId=66a089390309, content=感谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201023/49eab975a6db4be1bef93f13c6ec2d3a/5bd6a0e380d848ee9bce0e7a2b13b17f.jpg, createdBy=a2472553017, createdName=12547532m70暂无昵称, createdTime=Fri Oct 23 08:08:16 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881156, encodeId=04fa881156e7, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42705312246, createdName=1488d5e7m58暂无昵称, createdTime=Mon Aug 31 06:10:49 CST 2020, time=2020-08-31, status=1, ipAttribution=)]
    2022-04-11 ms7000001622695942

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1210257, encodeId=e2b5121025e87, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecd78109752, createdName=ms7000001622695942, createdTime=Mon Apr 11 11:14:01 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073423, encodeId=379910e3423f3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d14a5680833, createdName=ms7000001489181623, createdTime=Wed Nov 24 09:02:40 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894672, encodeId=96b28946e258, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28d31772992, createdName=ms2071255438096128, createdTime=Mon Oct 26 23:51:31 CST 2020, time=2020-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893903, encodeId=66a089390309, content=感谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201023/49eab975a6db4be1bef93f13c6ec2d3a/5bd6a0e380d848ee9bce0e7a2b13b17f.jpg, createdBy=a2472553017, createdName=12547532m70暂无昵称, createdTime=Fri Oct 23 08:08:16 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881156, encodeId=04fa881156e7, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42705312246, createdName=1488d5e7m58暂无昵称, createdTime=Mon Aug 31 06:10:49 CST 2020, time=2020-08-31, status=1, ipAttribution=)]
    2021-11-24 ms7000001489181623

    好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1210257, encodeId=e2b5121025e87, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecd78109752, createdName=ms7000001622695942, createdTime=Mon Apr 11 11:14:01 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073423, encodeId=379910e3423f3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d14a5680833, createdName=ms7000001489181623, createdTime=Wed Nov 24 09:02:40 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894672, encodeId=96b28946e258, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28d31772992, createdName=ms2071255438096128, createdTime=Mon Oct 26 23:51:31 CST 2020, time=2020-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893903, encodeId=66a089390309, content=感谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201023/49eab975a6db4be1bef93f13c6ec2d3a/5bd6a0e380d848ee9bce0e7a2b13b17f.jpg, createdBy=a2472553017, createdName=12547532m70暂无昵称, createdTime=Fri Oct 23 08:08:16 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881156, encodeId=04fa881156e7, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42705312246, createdName=1488d5e7m58暂无昵称, createdTime=Mon Aug 31 06:10:49 CST 2020, time=2020-08-31, status=1, ipAttribution=)]
    2020-10-26 ms2071255438096128

    好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1210257, encodeId=e2b5121025e87, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecd78109752, createdName=ms7000001622695942, createdTime=Mon Apr 11 11:14:01 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073423, encodeId=379910e3423f3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d14a5680833, createdName=ms7000001489181623, createdTime=Wed Nov 24 09:02:40 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894672, encodeId=96b28946e258, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28d31772992, createdName=ms2071255438096128, createdTime=Mon Oct 26 23:51:31 CST 2020, time=2020-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893903, encodeId=66a089390309, content=感谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201023/49eab975a6db4be1bef93f13c6ec2d3a/5bd6a0e380d848ee9bce0e7a2b13b17f.jpg, createdBy=a2472553017, createdName=12547532m70暂无昵称, createdTime=Fri Oct 23 08:08:16 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881156, encodeId=04fa881156e7, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42705312246, createdName=1488d5e7m58暂无昵称, createdTime=Mon Aug 31 06:10:49 CST 2020, time=2020-08-31, status=1, ipAttribution=)]
    2020-10-23 12547532m70暂无昵称

    感谢分享。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1210257, encodeId=e2b5121025e87, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecd78109752, createdName=ms7000001622695942, createdTime=Mon Apr 11 11:14:01 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073423, encodeId=379910e3423f3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d14a5680833, createdName=ms7000001489181623, createdTime=Wed Nov 24 09:02:40 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894672, encodeId=96b28946e258, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28d31772992, createdName=ms2071255438096128, createdTime=Mon Oct 26 23:51:31 CST 2020, time=2020-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893903, encodeId=66a089390309, content=感谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201023/49eab975a6db4be1bef93f13c6ec2d3a/5bd6a0e380d848ee9bce0e7a2b13b17f.jpg, createdBy=a2472553017, createdName=12547532m70暂无昵称, createdTime=Fri Oct 23 08:08:16 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881156, encodeId=04fa881156e7, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42705312246, createdName=1488d5e7m58暂无昵称, createdTime=Mon Aug 31 06:10:49 CST 2020, time=2020-08-31, status=1, ipAttribution=)]
    2020-08-31 1488d5e7m58暂无昵称

    值得学习

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2014 EHF共识声明：难治性慢性偏头痛的临床定义

欧洲头痛联盟(EHF,European Headache Federation) · 2014-08-28

2012AAN NSAID和其他补充剂防治成人发作性偏头痛循证指南

美国神经病学学会(AAN,American Academy of Neurology) · 2012-04-24

2012 AAN 成人阵发性偏头痛预防药物治疗循证指南

美国神经病学学会(AAN,American Academy of Neurology) · 2012-04-24

偏头痛药物对照试验指南：第3版

国际头痛协会(IHS,International Headache society) · 2012-01-01

2011 中国偏头痛诊断治疗指南

中华医学会疼痛学分会头面痛学组 · 2011-02-01

偏头痛、紧张型头痛、丛集性头痛、药物过度使用头痛的所有医疗专业人员的诊治指南

英国头痛研究学会(BASH,British Association for the study of Headache) · 2010-03-07